1
2
#OpenInnovation
3
4
News & Events
InterVenn Demonstrates Power of Its GlycoVision™ Platform
May 8, 2023
GlycoVision achieved high sensitivity and specificity in predicting advanced adenoma and colorectal cancer. Read more
GreenLight Biosciences Outlines Development Strategy and Highlights Portfolio Updates
March 7, 2022
Company outlines its pipeline strategy and R&D progress for crop protection and plant delivery innovations. Read more
Foghorn Therapeutics Highlights Recent Clinical and Research Progress
January 9, 2023
Also announced strategic objectives for 2023. Read more
5
#knowledgebase
6
7
News & Events
InterVenn Demonstrates Power of Its GlycoVision™ Platform
May 8, 2023
GlycoVision achieved high sensitivity and specificity in predicting advanced adenoma and colorectal cancer. Read more
GreenLight Biosciences Outlines Development Strategy and Highlights Portfolio Updates
March 7, 2022
Company outlines its pipeline strategy and R&D progress for crop protection and plant delivery innovations. Read more
Foghorn Therapeutics Highlights Recent Clinical and Research Progress
January 9, 2023
Also announced strategic objectives for 2023. Read more
8
Portfolio Highlights
#PharmaBiotech
11
Our View
10
Our Focus
12
#PRI
22
Medical Technologies
#Portfolio
14
Championing
collaborations
that improve health
and the quality of life
for everyone.
#JoinForces
#LifeSciencesInTheFuture
16
Words from
the CEO
17
Portfolio Highlights
#PharmaBiotech
28
Pharmaceutical Biotech
#Portfolio
15
About Us
34
Biorenewables & Others
#Portfolio
19
WHAT'S TRENDING @ XERAYA
InterVenn Demonstrates GlycoVision™ Platform
20
Our Team
21
23
Portfolio Highlights
#Biorenewables
30
Portfolio Highlights
#MedTech
25
26
ARE YOU
The Next
Big Thing?
Submit
A
Proposal
29
36
Career
#Xeraya
35
37
News & Events
InterVenn Demonstrates Power of Its GlycoVision™ Platform
May 8, 2023
GlycoVision achieved high sensitivity and specificity in predicting advanced adenoma and colorectal cancer. Read more
GreenLight Biosciences Outlines Development Strategy and Highlights Portfolio Updates
March 7, 2022
Company outlines its pipeline strategy and R&D progress for crop protection and plant delivery innovations. Read more
Foghorn Therapeutics Highlights Recent Clinical and Research Progress
January 9, 2023
Also announced strategic objectives for 2023. Read more
32
#agro
33
Portfolio Highlights
#Biorenewables
38
Portfolio Highlights
#MedTech
39
40
Contact Us
41
